Telemedicine Clinic for Prostate Cancer Patients

Not Applicable

• Conditions: Cancer, Treatment-Related

• Registration Number: NCT03413865
• Lead Sponsor: Grand River Hospital

Brief Summary

This randomized, open label study will evaluate a nurse and pharmacist led clinic conducted remotely from Grand River Regional Cancer Centre at Grand River Hospital (GRRCC/GRH) using OTN teleconferencing as a platform for patients with prostate cancer receiving oral chemotherapy agents.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-10-28
• Study First Submitted: 2018-01-12
• Study First Submitted QC: 2018-01-22
• Study First Posted: 2018-01-29
• Status Verified: 2019-02
• Last Update Submitted: 2019-02-12
• Last Update Posted: 2019-02-15
• Primary Completion: 2020-10
• Study Completion: 2021-06

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: Male
• Target Recruitment: 80

Inclusion Criteria

1. Male over 18 years of age with prostate cancer receiving oral treatment with abiraterone or enzalutamide.
2. Ability to provide consent to study.
3. Willingness to complete study questionnaires and a semi-structured exit interview.
4. Adequate command of the English language to complete study questionnaire and survey.
5. Access to technology to allow a link to the virtual telemedicine clinic. (excluding control group)
6. Willingness to participate in videoconference with pharmacist or nurse from their home environment. (excluding control group)

Exclusion Criteria

1. Patients receiving oral anti-cancer therapy other than abiraterone and enzalutamide.

2. Patients lacking the technology at home to participate in the virtual telemedicine clinic. (excluding control group)

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Patient satisfaction with overall care	2 Years	The primary outcome will be a comparison of patient satisfaction with overall care utilizing a validated scale between the group of patients using the OTN clinic and a group of control patients receiving conventional care at GRRCC

Trial Locations

Locations (1)

Grand River Hospital; 🇨🇦 Kitchener, Ontario, Canada